摘要

<正>1文献来源Garcia-Manero G,Gartenberg G,Steensma DP,et al.A phase 2,randomized,double-blind,multicenter study comparing Siltuximab plus best supportive care(BSC)with placebo plus BSC in anemic patients with International Prognostic Scoring System low-or intermediate-1-risk myelodysplastic syndrome[J].Am J Hematol,2014,89(9):e156-e162.